Plymouth Meeting, PA – October 27, 2015: CRF Health, the leading global provider of electronic Clinical Outcome Assessment (eCOA) solutions for the life sciences industry, today announced that its TrialMax App™ has successfully demonstrated usability and comparability during testing across a range of handheld devices.
To drive the industry wide effort to prove the feasibility of the BYOD methodology in clinical trials and exhibit the potential of its TrialMax App, CRF Health conducted the usability study using an app-based version of a vaccine report card to explore consistency in patient interpretation of questions and responses, irrespective of the device interacted with. Patient feedback was overwhelmingly positive and demonstrated taking part in a clinical trial using a familiar electronic device to be greatly preferred by all patients involved over using a paper report card.
Commenting on the study, Paul O’Donohoe, Director of Health Outcomes at CRF Health, said: “We are excited to be driving the industry effort of exploring BYOD and helping to move the area forward by conducting research into its use across multiple study phases. Our findings demonstrate the feasibility of the BYOD methodology and further prove the quality of TrialMax App and its ability to provide a highly user-friendly method of capturing data in clinical trials.”
Launched earlier this year, CRF Health’s TrialMax App is a customizable eCOA app solution designed to simplify ePRO collection using patients’ own devices. TrialMax App has been developed to offer more convenient and familiar data capture to patients, and provide a discreet, offline solution to complete eDiaries anytime and anywhere. The solution is uniquely integrated with CRF Health’s TrialStudio® design tool that allows the creation of patient-centric apps in close collaboration with sponsor study teams. The system also enables sponsors to see how eCOA questionnaires are being created and adapted for their individual trial.